Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa [PDF]
, 2009 Bachmann, M +7 more
core
Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States. [PDF]
Drugs AgingKong AM +9 more
europepmc +1 more source
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum. [PDF]
Clin PharmacokinetYu Y +15 more
europepmc +1 more source
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19. [PDF]
Clin Transl SciBen Ghezala I +5 more
europepmc +1 more source
The effect of treatment cessation on HBsAg negativity in HBeAg-negative chronic hepatitis B patients treated with nucleos(t)id analogues for more than three years. [PDF]
BMC Infect DisSenol Yilmaz A, Turker N.
europepmc +1 more source
Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]
Neurol Neuroimmunol NeuroinflammTorkildsen Ø +3 more
europepmc +1 more source
A Real-Time Urine Tenofovir Assay Improves Drug Adherence Among People With HIV With Prior Virologic Failure in a Randomized Controlled Trial. [PDF]
Clin Infect Disvan Zyl GU +10 more
europepmc +1 more source
Comparative effectiveness of tenofovir versus entecavir combined with peginterferon Alfa-2b for functional cure in HBeAg-negative chronic hepatitis B: a propensity score-matched analysis. [PDF]
BMC Infect DisWang PP +6 more
europepmc +1 more source